Purpose <p>We evaluated surface electrical impedance myography (EIM) enhanced with machine learning to serve as a new office-based screening tool for neuromuscular disease</p> Methods <p>EIM of nine muscles was successfully performed in 119 adults and 111 children (approximately half healthy and half diseased) for a total of 3158 individual muscle measurements. Multifrequency data were processed with feature engineering and classification. Nested cross-validation assessed performance, with muscle-based predictions aggregated to participant via majority voting</p> Results <p>Single-feature analyses showed moderate-to-good discrimination (area-under-ROC curve of 0.62–0.73). When multifrequency features were used, participant-based logistic regression and extra trees ensemble models achieved 84% accuracy with 88.1% sensitivity in adults and 93% accuracy and 94.6% sensitivity in children. Beyond classification, regression using EIM predicted muscle strength with R<sup>2</sup> = 0.49, outperforming single-frequency correlations</p> Conclusion <p>These results demonstrate that machine learning-enhanced EIM can successfully distinguish individuals with neuromuscular disease from healthy individuals. Nevertheless, further studies in larger populations of people would help advance this technology to the point that it could serve as a convenient, office-based screening tool for neuromuscular disease.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Multifrequency Electrical Impedance Myography Enhanced with Machine Learning for Screening Patients with Neuromuscular Disorders

  • Buket Sonbas-Cobb,
  • Seward B. Rutkove,
  • Baoguo Wei,
  • Sara Robicheau,
  • W. David Arnold,
  • Kaneshia Hives,
  • Amy Bartlett,
  • Peter Riley,
  • Aleah Pagan,
  • Stephen M. Chrzanowski,
  • Basil T. Darras,
  • Stephen J. Kolb

摘要

Purpose

We evaluated surface electrical impedance myography (EIM) enhanced with machine learning to serve as a new office-based screening tool for neuromuscular disease

Methods

EIM of nine muscles was successfully performed in 119 adults and 111 children (approximately half healthy and half diseased) for a total of 3158 individual muscle measurements. Multifrequency data were processed with feature engineering and classification. Nested cross-validation assessed performance, with muscle-based predictions aggregated to participant via majority voting

Results

Single-feature analyses showed moderate-to-good discrimination (area-under-ROC curve of 0.62–0.73). When multifrequency features were used, participant-based logistic regression and extra trees ensemble models achieved 84% accuracy with 88.1% sensitivity in adults and 93% accuracy and 94.6% sensitivity in children. Beyond classification, regression using EIM predicted muscle strength with R2 = 0.49, outperforming single-frequency correlations

Conclusion

These results demonstrate that machine learning-enhanced EIM can successfully distinguish individuals with neuromuscular disease from healthy individuals. Nevertheless, further studies in larger populations of people would help advance this technology to the point that it could serve as a convenient, office-based screening tool for neuromuscular disease.